Inovio Pharmaceuticals, Inc. (INO)

United States Steel Revenue

Inovio Pharmaceuticals had revenue of $65.34K in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $283.10K, down -60.52% year-over-year. In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K, down -73.83%.

• Revenue (ttm): $283.10K
• Revenue Growth: -60.52%
• P/S Ratio: 156.56
• Revenue / Employee: $2,113
• Employees: 134
• Market Cap: 72.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	217.76K	-614.25K	-73.83%
Dec 31, 2023	832.01K	-9.43M	-91.89%
Dec 31, 2022	10.26M	8.49M	478.23%
Dec 31, 2021	1.77M	-5.64M	-76.05%
Dec 31, 2020	7.41M	3.30M	80.24%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.